| Ytd | 11.84% | |
| 1y | 36.59% |
| Open | 22.74 | Prev Close | 22.75 | Low | 22.74 | High | 23.61 | Mkt Cap | 456.09M |
| Vol | 110.71K | Avg Vol | 219.63K | EPS | -4.57 | P/E | N/A | Forward P/E | -10.16 |
| Beta | 3.28 | Short Ratio | 3.54 | Inst. Own | 46.91% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 29.63 | 200-d Avg | 28.06 | 1yr Est | 74.67 |
Wells Fargo analyst Tiago Fauth maintains Tectonic Therapeutic (NASDAQ:TECX) with a Overweight an
Tectonic Therapeutic (NASDAQ:TECX) reported quarterly losses of $(1.18) per share which beat the ana
Raymond James analyst Michael Freeman upgrades Tectonic Therapeutic (NASDAQ:TECX) from Outperform
Tectonic Therapeutic (NASDAQ:TECX) reported quarterly losses of $(1.34) per share which missed the a
Stifel analyst James Condulis initiates coverage on Tectonic Therapeutic (NASDAQ:TECX) with a Buy
Tectonic Therapeutic (NASDAQ:TECX) reported quarterly losses of $(1.03) per share which beat the ana